SynthesisBMC gastroenterology2020

The clinical efficacy and adverse effects of Entecavir plus Thymosin alpha-1 combination therapy versus Entecavir Monotherapy in HBV-related cirrhosis: a systematic review and meta-analysis.

Dan Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.